Ali FarhoudianSeyed Ramin RadfarHossein Mohaddes ArdabiliParnian RafeiMohsen EbrahimiArash Khojasteh ZonooziCornelis A.J. De JongMehrnoosh VahidiMasud YunesianChristos KouimtsidisShalini ArunogiriHelena HansenKathleen T. BradyMarc N. PotenzaAlexander Mario BaldacchinoHamed EkhtiariAdrian Octavian AbagiuFranck David Noel AbounaMohamed Hassan AhmedBasma Al-AnsariFeda Mahmmoud Abu Al-KhairMandhar Humaid AlmaqbaliAtul AmbekarSidharth AryaVictor Olufolahan AsebikanMurad Ali AyasrehDebasish BasuZoubir BenmebarekRoshan BhadMario BlaiseNicolas BonnetJennifer BraschBarbara BroersAnja BusseJenna L. ButnerMoses CamilleriGiovanna CampelloGiuseppe CarraIvan CelicFatemeh ChalabianlooAbhishek ChaturvediJosé de Jesús Eduardo Noyola CherpitelKelly J. ClarkMelissa Anne CydersErnesto de BernardisAbbas DeilamizadeJohn Edward DerryNaveen Kumar DhaguduPavla DolezalovaGeert DomAdrian John DunlopMahmoud Mamdouh ElhabibyHussein ElkholyNsidibe Francis EssienGhandi Ilias FarahMarica FerriGeorgios D. FlorosCatherine FriedmanClara Hidalgo FuderananGilberto GerraAbhishek GhoshMaka GogiaIlias A. GrammatikopoulosPaolo GrandinettiAmira GuirguisDavid GutniskyPaul Steven HaberPeyman Hassani-AbharianZahra HooshyariIslam Ibrahim Mokhtar IbrahimHada Fong Ha IeongRegina Nova IndradewiShelly IskandarThahir Noorul IsraShobhit JainSandi JamesSeyyed Mohammad Hossein JavadiKeun Ho JoeDarius JokubonisAcka Tushevska JovanovaRama Mohamed KamalAlexander Ivanov KantchelovPreethy KathiresanGary KatzmanPaul KawaleAudrey Margaret KernFelix Henrique Paim KesslerSung Gon Sue KimAnn Marie KimballZeljko KljucevicKristiana Siste KurniasantiRoneet LevHae Kook LeeAiste LengvenyteShaul Lev-RanGeni Seseja MabelyaMohamed Ali El MahiJ. Maphisa MaphisaIcro MaremmaniLaura MasferrerPusan National University Yangsan HospitalIranian National Center for Addiction StudiesCollege of Medicine, University of IbadanPsychiatry and Behavioral Sciences Research CenterMichael G. DeGroote School of MedicineSchool of Public HealthSchool of Advanced Technologies in MedicineSwansea University Medical SchoolSurrey and Borders Partnership NHS Foundation TrustLaureate Institute for Brain ResearchThe University of Sydney School of MedicineMelaka-Manipal Medical College, Manipal UniversityPsychiatric Hospital Vrap?eUnited Nations Office on Drugs and Crime, AustriaUniversity of Social Welfare and Rehabilitation SciencesMinistry of Health OmanUniversité de Yaoundé IUniversitas PadjadjaranUniversitas IndonesiaVilniaus UniversitetasAl-Ahliyya Amman UniversityConnecticut Mental Health CenterHaukeland UniversitetssjukehusCUNY School of MedicineUniversità di PisaTehran University of Medical SciencesThe University of SydneyIndiana University-Purdue University IndianapolisUniversity of TehranUniversity of St AndrewsNew York UniversityUniversity of BotswanaAin Shams UniversityRadboud UniversiteitAristotle University of ThessalonikiAin Shams University, Faculty of MedicineScripps Mercy HospitalUniversiteit AntwerpenUniversità degli Studi di Milano-BicoccaBrown UniversityEastern HealthHôpitaux Universitaires de GenèveUniversitat de GironaAll India Institute of Medical Sciences, New DelhiUniversidade Federal do Rio Grande do SulJane & Terry Semel Institute for Neuroscience & Human BehaviorYale UniversityMUSC College of MedicineThe Catholic University of KoreaUniversidad de Buenos AiresMashhad University of Medical Sciences, School of MedicineThe Mount Sinai Medical CenterPostgraduate Institute of Medical Education & Research, ChandigarhSerT LentiniAddiction Medicine ClinicAddiction Medicine ClinicAddiction Medicine ClinicUniveristi Malaysia SabahSobriety Centers of New HampshireOrganization Against DrugsAddiction medicine clinicEuropean Monitoring Centre for Drugs and Drug Addiction (EMCDDA)Addiction Medicine ClinicRéseau de Prévention des Addictions (RESPADD)AġenzijaHayat Center for Treatment and Psycho-social RehabilitationNational Narcotics Board of IndonesiaSerenity Vista Addiction Treatment CenterAddiction Crisis SolutionsCommunity Health WorkNational Center for Mental Health of KoreaIsrael Center on AddictionFuderanan Mental Health ClinicDrug & Alcohol Clinical ServicesNaufar InstituteRepublican Center for Addictive DisordersESIC Medical CollegePt BDS University of Health SciencesAl-Amal Psychiatric HospitalGeorgian Harm Reduction NetworkChatham HouseCentre medical MarmottanAfrican Institute for Development PolicyNational Institute of Mental HealthRebirth Charity Society NGOInstitute for Cognitive Science StudiesPublic Health Institute of Split-Dalmatia CountyHeritage Institute of Medical SciencesNational Institute for Infectious DiseasesCentre for Research and Information on Substance AbuseKantchelov ClinicASL TeramoNational Institute of Education2022-08-042022-08-042021-08-06Frontiers in Psychiatry. Vol.12, (2021)166406402-s2.0-85113236018https://repository.li.mahidol.ac.th/handle/20.500.14594/77971Background and Aims: COVID-19 has infected more than 77 million people worldwide and impacted the lives of many more, with a particularly devastating impact on vulnerable populations, including people with substance use disorders (SUDs). Quarantines, travel bans, regulatory changes, social distancing, and “lockdown” measures have affected drug and alcohol supply chains and subsequently their availability, price, and use patterns, with possible downstream effects on presentations of SUDs and demand for treatment. Given the lack of multicentric epidemiologic studies, we conducted a rapid global survey within the International Society of Addiction Medicine (ISAM) network in order to understand the status of substance-use patterns during the current pandemic. Design: Cross-sectional survey. Setting: Worldwide. Participants: Starting on April 4, 2020 during a 5-week period, the survey received 185 responses from 77 countries. Measurements: To assess addiction medicine professionals' perceived changes in drug and alcohol supply, price, use pattern, and related complications during the COVID-19 pandemic. Findings: Participants reported (among who answered “decreased” or “increased”) a decrease in drug supply (69.0%) and at the same time an increase in price (95.3%) globally. With respect to changes in use patterns, an increase in alcohol (71.7%), cannabis (63.0%), prescription opioids (70.9%), and sedative/hypnotics (84.6%) use was reported, while the use of amphetamines (59.7%), cocaine (67.5%), and opiates (58.2%) was reported to decrease overall. Conclusions: The global report on changes in the availability, use patterns, and complications of alcohol and drugs during the COVID-19 pandemic should be considered in making new policies and in developing mitigating measures and guidelines during the current pandemic (and probable future ones) in order to minimize risks to people with SUD.Mahidol UniversityMedicineArticleSCOPUS10.3389/fpsyt.2021.646206